<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03756779</url>
  </required_header>
  <id_info>
    <org_study_id>122016-032</org_study_id>
    <nct_id>NCT03756779</nct_id>
  </id_info>
  <brief_title>Cross-over Pilot Study of Blood Cholesterol Response to Dietary Saturated Fat in Patients With Autosomal Dominant Hypercholesterolemia</brief_title>
  <official_title>Randomized, Cross-over Pilot Study of Blood Cholesterol Response to Dietary Saturated Fat in Patients With Autosomal Dominant Hypercholesterolemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We are performing a pilot cross-over diet study involving 5 patients with heterozygous FH and&#xD;
      5 patients with unexplained ADH. The patients will be randomized to a low versus high&#xD;
      saturated fat diet for 4 weeks each. We hypothesize that patients with unexplained ADH may&#xD;
      have an exaggerated cholesterol response to saturated fat intake. The specific aim of this&#xD;
      study is to quantify the increase in LDL-C in unexplained ADH patients compared to FH&#xD;
      patients. The pilot study proposed here will develop preliminary data to be used for future&#xD;
      funding proposals of larger, randomized studies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Not enrolling subjects in the study.&#xD;
  </why_stopped>
  <start_date type="Actual">May 15, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in LDL-cholesterol</measure>
    <time_frame>4 weeks</time_frame>
    <description>To quantify the change in low density lipoprotein cholesterol</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Familial Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Low Saturated Fat Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Goal will be to attain &lt;7% of daily calories from saturated fat. Replace it with energy from monounsaturated fat.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Saturated Fat Diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Goal will be to attain 15% of daily calories from saturated fat. Decrease intake of monounsaturated fat.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary intervention</intervention_name>
    <description>Dietary intervention with dietary modification of fat intake.</description>
    <arm_group_label>High Saturated Fat Diet</arm_group_label>
    <arm_group_label>Low Saturated Fat Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults, age &gt; 18 years or &lt; 80 years&#xD;
&#xD;
          2. Pre-treatment LDL-C greater than the 95th percentile for age and sex (corresponding to&#xD;
             190 mg/dL for most adults), with one of the 2 following criteria: (1) tendon xanthoma&#xD;
             (proband or first-degree relative) or (2) either first-degree relative with premature&#xD;
             CHD (age less than 55 years in men or 65 years in women) or pretreatment LDL-C greater&#xD;
             than the 95th percentile for age and sex.&#xD;
&#xD;
          3. Willing to come off medical therapy 4 weeks before and during study.&#xD;
&#xD;
          4. Willing to follow high/low saturated fat diet&#xD;
&#xD;
          5. Willing to attend dietary counseling sessions&#xD;
&#xD;
          6. Willing to attend frequent clinic visits&#xD;
&#xD;
          7. Subjects willing to participate under the conditions described in the informed consent&#xD;
             form (ICF) and able to sign the ICF and applicable HIPAA forms.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Presence of any clinically significant uncontrolled endocrine disease known to&#xD;
             influence serum lipids or lipoproteins. Note: patients on thyroid replacement therapy&#xD;
             can be included if the dosage of thyroxine has been stable for 6 weeks prior to the&#xD;
             first study visit and thyroid-stimulating hormone (TSH) level is within the normal&#xD;
             range.&#xD;
&#xD;
          2. Conditions of severe acute vascular stress (e.g. acute coronary syndrome, ischemic&#xD;
             stroke, or major vascular surgery) within 3 months prior to the first study visit.&#xD;
&#xD;
          3. Patients unable to maintain their current activity level or planning to increase their&#xD;
             activity level (e.g. new exercise regimen).&#xD;
&#xD;
          4. Pregnant or breast-feeding women.&#xD;
&#xD;
          5. Major illness&#xD;
&#xD;
          6. Secondary cause of dyslipidemia (e.g. obstructive liver disease, hypothyroidism, or&#xD;
             nephrotic syndrome)&#xD;
&#xD;
          7. Hospitalization within 3 months&#xD;
&#xD;
          8. Substance abuse (illegal drug use, chronic alcoholism or problematic use of alcohol or&#xD;
             total daily alcohol intake &gt;2 drinks per day in men and &gt; 1 drink per day in women).&#xD;
&#xD;
          9. Immunodeficiency or HIV-positive status&#xD;
&#xD;
         10. Illiteracy&#xD;
&#xD;
         11. Severe medical condition that may impair the ability of the person to participate in a&#xD;
             nutrition intervention study (e.g. digestive disease with fat intolerance, advanced&#xD;
             malignancy, or major neurological, psychiatric or endocrine disease)&#xD;
&#xD;
         12. Any other medical condition thought to limit survival to less than 1 year&#xD;
&#xD;
         13. Difficulties or major inconvenience to change dietary habits&#xD;
&#xD;
         14. History of food allergy with hypersensitivity to any of the components of olive oil or&#xD;
             nuts&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>July 28, 2017</study_first_submitted>
  <study_first_submitted_qc>November 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2018</study_first_posted>
  <last_update_submitted>November 26, 2018</last_update_submitted>
  <last_update_submitted_qc>November 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diet study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipoproteinemia Type II</mesh_term>
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

